Genmab — November 2024
-
-
Michigan Oncologist Charged in Scheme to Illegally Sell Cancer Drugs -According to the indictment, Aslam acquired and sold more than $17 million in cancer drugs and personally netted more than $2.5 million during the scheme. https://www.medscape.com/viewarticle/michigan-oncologist-charged-scheme-illegally-sell-cancer-2024a1000jz0?form=fpf
-
-
@EL yesterday 14:10, could it be related to this combination ? https://patents.google.com/patent/JP2024109764A
-
English version https://patents.google.com/patent/AU2019266205A1/en
-
Ja, JB ved jo ikke, om markedet er entydigt; det er blot et gæt. Jeg mener, at markedet også tager patentudløbet på Darzalex i betragtning, ligesom det muligvis ikke har store forventninger til Gen 42 og 46. Derudover er der nu højere omkostninger forbundet med at forberede Gen 46, nu hvor Genmab ejer 100%.
-
Hvis markedet ikke har store forventninger til Gen 42 og 46, kan det helt klart påvirke vurderingen. De højere omkostninger ved at forberede Gen 46, nu hvor Genmab ejer 100 %, er en væsentlig faktor, der kan påvirke virksomhedens økonomiske situation. Omvendt vil positive data for Gen 42 og 46 kunne ændre billedet fundamentalt, især da peaksalget for Gen 46 er enormt. Jeg er ikke helt sikker på det forventede peaksalg for Gen 42, men konservativt vurderet er det vel mindst 3 milliarder USD
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind